연구성과로 돌아가기
2020 연구성과별 연구자 정보 (667 / 2428)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Effects of Sublethal Doses of Methyl Benzoate on the Life History Traits and Acetylcholinesterase (AChE) Activity of Aphis gossypii | Shim, Jae-Kyoung | Shim, JK | 5 | Kyungpook Natl Univ, Inst Agr Sci & Technol, Daegu 41566, South Korea | munirmostafiz12@gmail.com;mbalam@knu.ac.kr;hsinchi@dragon.nchu.edu.tw;e.hassan@uq.edu.au;astelia@naver.com;leeky@knu.ac.kr; | |||||
| Effects of Sublethal Doses of Methyl Benzoate on the Life History Traits and Acetylcholinesterase (AChE) Activity of Aphis gossypii | Lee, Kyeong-Yeoll | Lee, KY | 6 | 교신저자 | Kyungpook Natl Univ, Coll Agr & Life Sci, Div Appl Biosci, Daegu 41566, South Korea | 0000-0002-0534-1942 | Lee, Kyeong-Yeoll | munirmostafiz12@gmail.com;mbalam@knu.ac.kr;hsinchi@dragon.nchu.edu.tw;e.hassan@uq.edu.au;astelia@naver.com;leeky@knu.ac.kr; | ||
| Effects of Sublethal Doses of Methyl Benzoate on the Life History Traits and Acetylcholinesterase (AChE) Activity of Aphis gossypii | Lee, Kyeong-Yeoll | Lee, KY | 6 | 교신저자 | Kyungpook Natl Univ, Sustainable Agr Res Ctr, Gunwi 39061, South Korea | 0000-0002-0534-1942 | Lee, Kyeong-Yeoll | munirmostafiz12@gmail.com;mbalam@knu.ac.kr;hsinchi@dragon.nchu.edu.tw;e.hassan@uq.edu.au;astelia@naver.com;leeky@knu.ac.kr; | ||
| Effects of Sublethal Doses of Methyl Benzoate on the Life History Traits and Acetylcholinesterase (AChE) Activity of Aphis gossypii | Lee, Kyeong-Yeoll | Lee, KY | 6 | 교신저자 | Kyungpook Natl Univ, Res Inst Dok Do & Ulleung Do Isl, Daegu 41566, South Korea | 0000-0002-0534-1942 | Lee, Kyeong-Yeoll | munirmostafiz12@gmail.com;mbalam@knu.ac.kr;hsinchi@dragon.nchu.edu.tw;e.hassan@uq.edu.au;astelia@naver.com;leeky@knu.ac.kr; | ||
| Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma | Alsina, Angel | Alsina, A | 1 | 교신저자 | Tampa Gen Hosp, Transplant & Specialty Serv, Tampa, FL 33606 USA | E-5347-2010 | Alsina, Angel | aalsina@tgmg.org; | ||
| Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma | Kudo, Masatoshi | Kudo, M | 2 | Kindai Univ, Dept Med, Osaka, Japan | AAA-9744-2019 | Kudo, Masatoshi | 0000-0002-4102-3474 | Kudo, Masatoshi | aalsina@tgmg.org; | |
| Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma | Vogel, Arndt | Vogel, A | 3 | Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany | A-8437-2012 | Vogel, Arndt | 0000-0003-0560-5538 | Vogel, Arndt | aalsina@tgmg.org; | |
| Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma | Cheng, Ann-Lii | Cheng, AL | 4 | Natl Taiwan Univ Hosp, Dept Med Oncol, Taipei, Taiwan | ACM-0936-2022 | Cheng, Ann-Lii | aalsina@tgmg.org; | |||
| Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma | Cheng, Ann-Lii | Cheng, AL | 4 | Natl Taiwan Univ, Ctr Canc, Taipei, Taiwan | ACM-0936-2022 | Cheng, Ann-Lii | aalsina@tgmg.org; | |||
| Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma | Tak, Won Young | Tak, WY | 5 | Kyungpook Natl Univ, Dept Internal Med, Sch Med, Daegu, South Korea | aalsina@tgmg.org; | |||||
| Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma | Ryoo, Baek-Yeol | Ryoo, BY | 6 | Asan Med Ctr, Dept Oncol, Seoul, South Korea | aalsina@tgmg.org; | |||||
| Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma | Ryoo, Baek-Yeol | Ryoo, BY | 6 | Univ Ulsan, Coll Med, Seoul, South Korea | aalsina@tgmg.org; | |||||
| Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma | Evans, Thomas R. Jeffry | Evans, TRJ | 7 | Univ Glasgow, Inst Canc Sci, Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland | aalsina@tgmg.org; | |||||
| Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma | Lopez Lopez, Carlos | López, CL | 8 | Marques de Valdecilla Univ Hosp, Oncol Serv, IDIVAL, Santander, Spain | ABP-9145-2022 | LOPEZ, CARLOS | 0000-0002-8901-741X | Lopez Lopez, Carlos | aalsina@tgmg.org; | |
| Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma | Daniele, Bruno | Daniele, B | 9 | Azienda Osped G Rummo, Dept Oncol, Benevento, Italy | IAR-5511-2023 | Daniele, Bruno | aalsina@tgmg.org; |
페이지 이동: